Dova Pharmaceuticals (DOVA) Short Interest Ratio & Short Volume → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free DOVA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Dova Pharmaceuticals Short Interest DataCurrent Short Volume572,700 sharesPrevious Short Volume1,190,000 sharesChange Vs. Previous Month-51.87%Dollar Volume Sold Short$16.06 millionShort Interest Ratio / Days to Cover1.0Last Record DateNovember 15, 2019Outstanding Shares28,800,000 sharesFloat Size13,000,000 sharesShort Percent of Float4.41%Today's Trading Volume35,036 sharesAverage Trading Volume499,313 sharesToday's Volume Vs. Average7% Short Selling Dova Pharmaceuticals ? Sign up to receive the latest short interest report for Dova Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDOVA Short Interest Over TimeDOVA Days to Cover Over TimeDOVA Percentage of Float Shorted Over Time Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read Dova Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/2019572,700 shares $16.06 million -51.9%4.4%1 $28.04 8/15/20193,420,600 shares $51.27 million -12.3%28.2%8.8 $14.99 DOVA Short Interest - Frequently Asked Questions What is Dova Pharmaceuticals' current short interest? Short interest is the volume of Dova Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 572,700 shares of DOVA short. 4.41% of Dova Pharmaceuticals' shares are currently sold short. Learn More on Dova Pharmaceuticals' current short interest. What is a good short interest ratio for Dova Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DOVA shares currently have a short interest ratio of 1.0. Learn More on Dova Pharmaceuticals's short interest ratio. What is a good short interest percentage for Dova Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.41% of Dova Pharmaceuticals' floating shares are currently sold short. Is Dova Pharmaceuticals' short interest increasing or decreasing? Dova Pharmaceuticals saw a drop in short interest in November. As of November 15th, there was short interest totaling 572,700 shares, a drop of 51.9% from the previous total of 1,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Dova Pharmaceuticals' float size? Dova Pharmaceuticals currently has issued a total of 28,800,000 shares. Some of Dova Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Dova Pharmaceuticals currently has a public float of 13,000,000 shares. How does Dova Pharmaceuticals' short interest compare to its competitors? 4.41% of Dova Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Dova Pharmaceuticals: Longboard Pharmaceuticals, Inc. (14.81%), Pliant Therapeutics, Inc. (12.63%), Sage Therapeutics, Inc. (18.98%), Tango Therapeutics, Inc. (19.37%), Evolus, Inc. (9.57%), Y-mAbs Therapeutics, Inc. (7.04%), SIGA Technologies, Inc. (12.30%), Arcturus Therapeutics Holdings Inc. (18.77%), Cogent Biosciences, Inc. (13.04%), PureTech Health plc (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RingCentral, Inc. ($862.50 million), Reata Pharmaceuticals, Inc. ($637.88 million), Immunomedics, Inc. ($530.84 million), Viacom, Inc. ($466.41 million), Glaukos Co. ($461.75 million), QTS Realty Trust, Inc. ($419.87 million), Smartsheet Inc ($418.21 million), Agios Pharmaceuticals, Inc. ($393.42 million), Premier, Inc. ($342.60 million), and ZIOPHARM Oncology, Inc. ($280.25 million). View all of the most shorted stocks. What does it mean to sell short Dova Pharmaceuticals stock? Short selling DOVA is an investing strategy that aims to generate trading profit from Dova Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dova Pharmaceuticals? A short squeeze for Dova Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DOVA, which in turn drives the price of the stock up even further. How often is Dova Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DOVA, twice per month. The most recent reporting period available is November, 15 2019. More Short Interest Resources from MarketBeat Related Companies: LBPH Short Interest PLRX Short Interest SAGE Short Interest TNGX Short Interest EOLS Short Interest YMAB Short Interest SIGA Short Interest ARCT Short Interest COGT Short Interest PRTC Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DOVA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable Prosperity